Acquired amegakaryocytic thrombocytopenic purpura (AATP): a hospital based study.
To determine the frequency of Acquired Amegakaryocytic Thrombocytopenic Purpura (AATT), possible aetiology, course and prognosis. Retrospectively diagnosed patients, treated and followed prospectively. Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi. One hundred twenty patients with thrombocytopenic purpura. Response to treatment and course of disease. Out of 22 patients 2 died of cerebral haemorrhage, one transformed to Myelodysplastic Syndrome (MDS), one transformed to Acute Myeloid Levkaenia (AML). None is transfusion independent. AATT is not an infrequent disorder. It shows poor response to all available therapeutic modalities and has a potential for transformation into Myelodysplasia and acute myeloid leukaemia.